ENANTONE LP 1.88 mg, powder and solvent for injectable suspension (s.c.) with extended release in a pre-filled syringe syringe, 1 ml
Active ingredients: Leuprolide acetate, LEUPRORÉLINE
Commercialized according to BDPMDispensing in France: Prescription only
Powder and solvent for injectable suspension with extended releasesyringe, 1 mlsous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ENANTONE LP 1,88 mg, poudre et solvant pour suspension injectable (S.C.) à libération prolongée en seringue pré-remplie
- Pharmaceutical form
- poudre et solvant pour suspension injectable à libération prolongée
- Route of administration
- sous-cutanée
- Presentation description
- 1 seringue(s) préremplie(s) bicompartimenté(e)(s)/à compartiments de 22,10 mg de poudre et de 1 ml de solvant avec système de sécurité
- Marketing authorisation holder
- TAKEDA FRANCE
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 30 Jun 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60054077CIP73023372CIP133400930233726Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LEUPRORÉLINEpoudre | 1,79 mg · une seringue pré-remplie | FT |
| ACÉTATE DE LEUPRORÉLINEpoudre | 1,88 mg · une seringue pré-remplie | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.